Skip to content

Study on acupuncture anesthesia assisted with percutaneous CT guided microwave ablation probe in the treatment of lung cancer

Study on acupuncture anesthesia assisted with percutaneous CT guided microwave ablation probe in the treatment of lung cancer

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000037340
Enrollment
Unknown
Registered
2020-08-28
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-10-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

Sponsors

Shanghai Pulmonary Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. No gender limit, age 18-80 years old; 2. Chest CT showed pulmonary nodules, and the nodules were ground glass nodules or solid nodules with the size of 5mm to 30mm; 3. It was confirmed by pathology as primary malignant tumor of lung, and had not received corresponding treatment. 4. Patients with early or very early lung cancer who are unable to undergo surgery or are unwilling to undergo surgery due to moderate or severe lung function decline. 5. The function of the main organs is normal, that is to say, it meets the following standards: The blood routine examination standard should meet the following requirements: HB >= 120g / L (no blood transfusion within 14 days); ANC >= 2.0 x 10^9/L; PLT >= 100 x 10^9/L; Biochemical examination should meet the following standards: Bil 50ml / min (Cockcroft Gault formula) 6. ECoG score 0-1; 7. The expected survival time was more than 1 year.

Exclusion criteria

Exclusion criteria: 1. Active tuberculosis (TB); 2. Abnormal coagulation function (PT > 16 S, APTT > 43 s, TT > 21 s, FBG < 2 g / L), bleeding tendency (such as active peptic ulcer) or undergoing thrombolytic or anticoagulant therapy; 3. Grade IV congestive heart failure (NYHA classification), poorly controlled and clinically significant arrhythmias and / or acute myocardial infarction within 3 months; 4. Patients with hematologic disease or other malignant tumors were not cured; 5. Pregnant women; 6. Mental patients; 7. The expected survival time was less than 1 year; 8. Chest spiral CT showed lung lesions or complete atelectasis, double lung bullae larger than 1 / 3 of the lobes; 9. ECoG score was more than 2 points; 10. Unable to cooperate or refuse to receive treatment or testing.

Design outcomes

Primary

MeasureTime frame
PFS;

Countries

China

Contacts

Public ContactDong Zhiyi

Shanghai Pulmonary Hospital

adreandong@126.com+86 13816922358

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026